Clinical Trials List
2022-03-01 - 2029-12-31
Phase III
Recruiting4
ICD-10E10.21
Type 1 diabetes mellitus with diabetic nephropathy
ICD-10E11.21
Type 2 diabetes mellitus with diabetic nephropathy
ICD-10N16
Renal tubulo-interstitial disorders in diseases classified elsewhere
ICD-9583.81
Nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Po-Hao Huang 風濕免疫科
- 張詩欣 風濕免疫科
- 黃建中 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Ming Chen 無
- HSIN-HUA CHEN 無
- 謝祖怡 無
- 廖育婉 無
- 陳彥如 無
- 林靖才 無
- LIN-SHIEN Fu 無
- Yi-Hsing Chen 未分科
- 譚國棟 無
- 謝佳偉 無
- 曾智偉 無
- 顏在弘 無
- WEN-NAN HUANG 無
- 吳沂達 無
- 洪維廷 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Syuan Sun 未分科
- Wei-Sheng Chen 無
- Chien-Chih Lai 未分科
- Hsien-Tzung Liao 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
462 participants
